{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:10:23Z","timestamp":1772712623944,"version":"3.50.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jns.2021.120012","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:16:38Z","timestamp":1633050998000},"page":"120012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The etiopathogenetic and pathophysiological spectrum of parkinsonism"],"prefix":"10.1016","volume":"433","author":[{"given":"Matteo","family":"Bologna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.jns.2021.120012_bb0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jns.2021.120012_bb0015","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.irn.2019.10.003","article-title":"Classification of atypical parkinsonism per pathology versus phenotype","volume":"149","author":"Respondek","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/WCO.0000000000000355","article-title":"Atypical parkinsonism - new advances","volume":"29","author":"Stamelou","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12703\/b\/9-6","article-title":"Recent advances in understanding and treatment of Parkinson's disease","volume":"9","author":"Tarakad","year":"2020","journal-title":"Fac. Rev."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120012_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.parkreldis.2020.11.017","article-title":"Parkinson\u2019s disease and skin","volume":"82","author":"Niemann","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"23","key":"10.1016\/j.jns.2021.120012_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239302","article-title":"New insights into immune-mediated mechanisms in Parkinson\u2019s disease","volume":"21","author":"Tan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaneurol.2020.5257","article-title":"Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets","volume":"78","author":"Kia","year":"2021","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000557","article-title":"Genome-wide association study Meta-analysis for Parkinson disease motor subtypes","volume":"7","author":"Alfradique-Dunham","year":"2021","journal-title":"Neurol. Genet."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.64.1.20","article-title":"Circuits and circuit disorders of the basal ganglia","volume":"64","author":"DeLong","year":"2007","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0075","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/mds.23695","article-title":"Milestones in research on the pathophysiology of Parkinson\u2019s disease","volume":"26","author":"Wichmann","year":"2011","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120012_bb0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/awz344","article-title":"Evolving concepts on bradykinesia","volume":"143","author":"Bologna","year":"2020","journal-title":"Brain"},{"issue":"Pt 3","key":"10.1016\/j.jns.2021.120012_bb0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/brain\/aws360","article-title":"The cerebellum in Parkinson's disease","volume":"136","author":"Wu","year":"2013","journal-title":"Brain"},{"issue":"41","key":"10.1016\/j.jns.2021.120012_bb0090","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","article-title":"Parkinson\u2019s disease is not simply a prion disorder","volume":"37","author":"Surmeier","year":"2017","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0095","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/ene.14851","article-title":"Emerging concepts on bradykinesia in non-parkinsonian conditions","volume":"28","author":"Paparella","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mds.26263","article-title":"Vascular parkinsonism: deconstructing a syndrome","volume":"30","author":"Vizcarra","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","article-title":"Vascular parkinsonism--characteristics, pathogenesis and treatment","volume":"11","author":"Korczyn","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25046","article-title":"Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration","volume":"82","author":"Espay","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious etiologies of parkinsonism: Pathomechanisms and clinical implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/bs.irn.2019.10.015","article-title":"Parkinsonism in autoimmune diseases","volume":"149","author":"Barba","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"Pt 1","key":"10.1016\/j.jns.2021.120012_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/brain\/awh008","article-title":"Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity","volume":"127","author":"Dale","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120012_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: An update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120012_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/bs.irn.2019.10.010","article-title":"Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults","volume":"149","author":"Hollerhage","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11910-019-0921-3","article-title":"Movement disorders in metabolic disorders","volume":"19","author":"Pedroso","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0145","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.parkreldis.2014.05.011","article-title":"Differentiating drug-induced parkinsonism from Parkinson\u2019s disease: an update on non-motor symptoms and investigations","volume":"20","author":"Brigo","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","article-title":"Toxin-induced parkinsonism","volume":"38","author":"McKnight","year":"2020","journal-title":"Neurol. Clin."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0155","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mdc3.13005","article-title":"Movement disorders and renal diseases","volume":"7","author":"Bhowmick","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2021.120012_bb0160","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and Meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.14336\/AD.2019.1125","article-title":"Relationships between mitochondrial dysfunction and neurotransmission failure in Alzheimer\u2019s disease","volume":"11","author":"Wong","year":"2020","journal-title":"Aging Dis."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0170","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0175","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","article-title":"The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"57","author":"Monzio Compagnoni","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"6301","key":"10.1016\/j.jns.2021.120012_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jns.2021.120012_bb0185","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tins.2019.10.002","article-title":"Lysosomal dysfunction at the Centre of Parkinson\u2019s disease and Frontotemporal dementia\/amyotrophic lateral sclerosis","volume":"42","author":"Wallings","year":"2019","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2021.120012_bb0195","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00702-012-0832-9","article-title":"Nigral tau pathology and striatal amyloid-\u03b2 deposition does not correlate with striatal dopamine deficit in Alzheimer\u2019s disease","volume":"119","author":"Schauer","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0200","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2021.120012_bb0205","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/jnnp.57.12.1503","article-title":"Extrapyramidalism in Alzheimer\u2019s disease: prevalence, psychiatric, and neuropsychological correlates","volume":"57","author":"Merello","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00002093-199601020-00008","article-title":"Extrapyramidal motor signs in clinically diagnosed Alzheimer disease","volume":"10","author":"Ellis","year":"1996","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-006-0146-9","article-title":"Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs","volume":"113","author":"Attems","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0220","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1994.00540190056015","article-title":"Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer\u2019s disease","volume":"51","author":"Chui","year":"1994","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0225","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.54.6.1284","article-title":"Progression of parkinsonian signs in Alzheimer\u2019s disease","volume":"54","author":"Wilson","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120012_bb0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer\u2019s disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2021.120012_bb0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network Meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2021.120012_bb0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fnagi.2020.00184","article-title":"Catecholamines in Alzheimer\u2019s disease: a systematic review and Meta-analysis","volume":"12","author":"Pan","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1179\/016164103101201166","article-title":"Decreased nigral neuromelanin in Alzheimer\u2019s disease","volume":"25","author":"Reyes","year":"2003","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jns.2021.120012_bb0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2019.10.007","article-title":"Presynaptic dopaminergic function in early-onset Alzheimer\u2019s disease: an FP-CIT image study","volume":"86","author":"Jang","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0255","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s004010050447","article-title":"No correlation between nigral degeneration and striatal plaques in Alzheimer\u2019s disease","volume":"91","author":"Love","year":"1996","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-019-0468-1","article-title":"Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer\u2019s disease","volume":"11","author":"Hanseeuw","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000509278","article-title":"Apathy in Alzheimer\u2019s disease correlates with the dopamine transporter level in the caudate nuclei","volume":"10","author":"Udo","year":"2020","journal-title":"Dement Geriatr. Cogn. Dis. Extra."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/17482968.2011.603732","article-title":"Parkinson-like features in ALS with predominant upper motor neuron involvement","volume":"13","author":"D\u2019Ascenzo","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0275","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00415-019-09305-0","article-title":"Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study","volume":"266","author":"Calvo","year":"2019","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0280","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000575","article-title":"Expanding the Spectrum of movement disorders associated with C9orf72 Hexanucleotide expansions","volume":"7","author":"Estevez-Fraga","year":"2021","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jns.2021.120012_bb0285","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneur.1996.00550100061015","article-title":"Motor neuron disease with parkinsonism","volume":"53","author":"Qureshi","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0290","article-title":"Parkinsonism and motor neuron disorders: lessons from Western Pacific ALS\/PDC","author":"Spencer","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0295","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ene.14849","article-title":"Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis","volume":"28","author":"Forrest","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"8878","key":"10.1016\/j.jns.2021.120012_bb0300","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0140-6736(93)92878-W","article-title":"Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning","volume":"342","author":"Takahashi","year":"1993","journal-title":"Lancet"},{"issue":"1\u22122","key":"10.1016\/j.jns.2021.120012_bb0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.11.017","article-title":"Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism","volume":"301","author":"Park","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120012_bb0310","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/archneur.63.12.1719","article-title":"A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis","volume":"63","author":"Hideyama","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0315","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp.65.2.263","article-title":"Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography","volume":"65","author":"Borasio","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0320","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00415-012-6654-8","article-title":"Parkinson\u2019s disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis","volume":"260","author":"Fathinia","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12883-015-0280-x","article-title":"The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses","volume":"15","author":"Hermann","year":"2015","journal-title":"BMC Neurol."},{"issue":"1\u22122","key":"10.1016\/j.jns.2021.120012_bb0330","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-510X(00)00429-9","article-title":"Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration","volume":"180","author":"Vogels","year":"2000","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0335","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.52.6.1275","article-title":"Decreased striatal dopamine-receptor binding in sporadic ALS: glutamate hyperactivity?","volume":"52","author":"Vogels","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120012_bb0340","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1212\/01.wnl.0000437313.80913.2c","article-title":"Basal ganglia involvement in amyotrophic lateral sclerosis","volume":"81","author":"Bede","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120012_bb0345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/jnnp-2016-314337","article-title":"Structural MRI correlates of amyotrophic lateral sclerosis progression","volume":"88","author":"Senda","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120012_bb0350","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.0000000000002017","article-title":"Basal ganglia pathology in ALS is associated with neuropsychological deficits","volume":"85","author":"Machts","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120012_bb0355","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/nbm.1687","article-title":"1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis","volume":"24","author":"Sharma","year":"2011","journal-title":"NMR Biomed."},{"issue":"9","key":"10.1016\/j.jns.2021.120012_bb0360","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00415-018-8964-y","article-title":"Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study","volume":"265","author":"Feron","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.03.013","article-title":"(18)F-fallypride PET-CT of dopamine D2\/D3 receptors in patients with sporadic amyotrophic lateral sclerosis","volume":"377","author":"Fu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jns.2021.120012_bb0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson\u2019s disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0380","doi-asserted-by":"crossref","first-page":"117331","DOI":"10.1016\/j.jns.2021.117331","article-title":"Parkinson\u2019s disease after COVID-19","volume":"422","author":"Makhoul","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0385","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide Pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.parkreldis.2021.05.026","article-title":"Movement disorders in systemic autoimmune diseases: clinical spectrum, ancillary investigations, pathophysiological considerations","volume":"88","author":"Menozzi","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.120012_bb0395","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S1474-4422(20)30341-0","article-title":"Sleep disorders in autoimmune encephalitis","volume":"19","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0400","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012639","article-title":"Frequency and characterization of movement disorders in anti-IgLON5 disease","author":"Gaig","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0405","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-170189","article-title":"Microglial and neuronal TDP-43 pathology in anti-IgLON5-related Tauopathy","volume":"59","author":"Cagnin","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.jns.2021.120012_bb0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.imbio.2017.10.036","article-title":"Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?","volume":"223","author":"Drori","year":"2018","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.10317","article-title":"Parkinsonism as a manifestation of multiple sclerosis","volume":"18","author":"Folgar","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0420","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/mds.21642","article-title":"A unique case of coincidence of early onset Parkinson\u2019s disease and multiple sclerosis","volume":"22","author":"Valkovic","year":"2007","journal-title":"Mov. Disord."},{"issue":"1\u22122","key":"10.1016\/j.jns.2021.120012_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.02.007","article-title":"Movement disorders in multiple sclerosis and other demyelinating diseases","volume":"328","author":"Mehanna","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0430","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/mds.870100403","article-title":"Movement disorders in multiple sclerosis","volume":"10","author":"Tranchant","year":"1995","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0435","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jocn.2009.09.026","article-title":"Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous methylprednisolone","volume":"17","author":"Saidha","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.jns.2021.120012_bb0440","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1177\/1352458508094883","article-title":"Movement disorders in multiple sclerosis: causal or coincidental association?","volume":"14","author":"Nociti","year":"2008","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.jns.2021.120012_bb0445","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.clineuro.2008.03.019","article-title":"Parkinsonism and multiple sclerosis--is there association?","volume":"110","author":"Barun","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0450","first-page":"818","article-title":"Movement disorders with multiple sclerosis","volume":"12","author":"Kamphorst","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0455","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial Fibrillary acidic protein Astrocytopathy: a review of the literature","volume":"9","author":"Shan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2021.120012_bb0460","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial Fibrillary acidic protein Astrocytopathy: a novel Meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0465","doi-asserted-by":"crossref","first-page":"101900","DOI":"10.1016\/j.msard.2019.101900","article-title":"A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism","volume":"39","author":"Tomczak","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0470","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s10067-005-0151-8","article-title":"Steroid-reversible parkinsonism as presentation of polymyalgia rheumatica","volume":"25","author":"Fietta","year":"2006","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0475","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/mds.25011","article-title":"Movement disorders in autoimmune diseases","volume":"27","author":"Baizabal-Carvallo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0480","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jns.2021.120012_bb0485","first-page":"1","article-title":"Acute parkinsonism in patients with systemic lupus erythematosus: a case report and review of the literature","author":"Wantaneeyawong","year":"2020","journal-title":"Int. J. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0490","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1191\/096120300678828578","article-title":"Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus","volume":"9","author":"Kwong","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jns.2021.120012_bb0495","doi-asserted-by":"crossref","first-page":"239398","DOI":"10.1155\/2014\/239398","article-title":"Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage","volume":"2014","author":"Carecchio","year":"2014","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0500","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2021.120012_bb0505","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-020-00123-0","article-title":"COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside","volume":"6","author":"Sulzer","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0510","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.braindev.2014.03.009","article-title":"Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood","volume":"37","author":"Rebai","year":"2015","journal-title":"Brain and Development"},{"key":"10.1016\/j.jns.2021.120012_bb0515","article-title":"Parkinsonism in viral, paraneoplastic, and autoimmune diseases","author":"Xing Frank","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0520","first-page":"1101","article-title":"Magnetic resonance imaging (MRI) and neurological manifestations in SARS-CoV-2 patients","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0525","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2021.120012_bb0530","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1021\/acschemneuro.0c00671","article-title":"Viral infection-induced gut Dysbiosis, Neuroinflammation, and \u03b1-Synuclein aggregation: updates and perspectives on COVID-19 and neurodegenerative disorders","volume":"11","author":"Follmer","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"22","key":"10.1016\/j.jns.2021.120012_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0540","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.parkreldis.2014.02.031","article-title":"Hypothesis: a role for EBV-induced molecular mimicry in Parkinson\u2019s disease","volume":"20","author":"Woulfe","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0545","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/WNL.0b013e3181b04b0d","article-title":"Parkinsonism in hiv-infected patients on highly active antiretroviral therapy","volume":"73","author":"Tisch","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0550","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mds.20742","article-title":"Acute reversible parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness","volume":"21","author":"Dimova","year":"2006","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.parkreldis.2005.11.004","article-title":"Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report","volume":"12","author":"Roselli","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0560","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mdc3.12943","article-title":"Reversible acute parkinsonism and unusual neuroimaging findings in systemic lupus Erythematosus","volume":"7","author":"Moraes de Moraes","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0565","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0028-1083688","article-title":"Neuroimaging of infections of the central nervous system","volume":"28","author":"Kastrup","year":"2008","journal-title":"Semin. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0570","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.27741","article-title":"Changing views of the pathophysiology of parkinsonism","volume":"34","author":"Wichmann","year":"2019","journal-title":"Mov. Disord."},{"issue":"Pt 4","key":"10.1016\/j.jns.2021.120012_bb0575","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0580","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mds.28366","article-title":"Striatal dopamine deficit and motor impairment in idiopathic Normal pressure hydrocephalus","volume":"36","author":"Pozzi","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0585","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/mds.28251","article-title":"Gaps, controversies, and proposed roadmap for research in Normal pressure hydrocephalus","volume":"35","author":"Fasano","year":"2020","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120012_bb0590","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00415-020-10267-x","article-title":"iNPH with parkinsonism: response to lumbar CSF drainage and ventriculoperitoneal shunting","volume":"268","author":"Mostile","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb0595","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00415-017-8598-5","article-title":"Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study","volume":"264","author":"Molde","year":"2017","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0600","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(13)70057-7","article-title":"Movement disorders in cerebrovascular disease","volume":"12","author":"Mehanna","year":"2013","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0605","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/brain\/awy161","article-title":"Localizing parkinsonism based on focal brain lesions","volume":"141","author":"Joutsa","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0610","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1600-0404.1992.tb05492.x","article-title":"Vascular pseudoparkinsonism","volume":"86","author":"Chang","year":"1992","journal-title":"Acta Neurol. Scand."},{"issue":"10\u201311","key":"10.1016\/j.jns.2021.120012_bb0615","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00702-004-0192-1","article-title":"Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort","volume":"111","author":"Peralta","year":"2004","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.jns.2021.120012_bb0620","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.40.6.897","article-title":"Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation","volume":"40","author":"Murrow","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000117089","article-title":"Parkinsonism in patients with lucanar infarcts of the basal ganglia","volume":"35","author":"Reider-Groswasser","year":"1995","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2021.120012_bb0630","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mds.870090503","article-title":"Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses","volume":"9","author":"Curran","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0635","doi-asserted-by":"crossref","first-page":"e2861","DOI":"10.1212\/WNL.0000000000012064","article-title":"Clinical outcome and striatal dopaminergic function after shunt surgery in patients with idiopathic Normal pressure hydrocephalus","volume":"96","author":"Todisco","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2021.120012_bb0640","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00415-008-0928-1","article-title":"Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH","volume":"255","author":"Akiguchi","year":"2008","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.120012_bb0645","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.clineuro.2008.03.008","article-title":"Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis","volume":"110","author":"Prashantha","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"Pt 11","key":"10.1016\/j.jns.2021.120012_bb0650","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/brain\/awr177","article-title":"The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration","volume":"134","author":"Cummings","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2021.120012_bb0655","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.28379","article-title":"Seven solutions for Neuroprotection in Parkinson\u2019s disease","volume":"36","author":"Devos","year":"2021","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2021.120012_bb0660","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.28187","article-title":"Stem cells: scientific and ethical quandaries of a personalized approach to Parkinson\u2019s disease","volume":"35","author":"Jankovic","year":"2020","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120012_bb0665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mds.26460","article-title":"Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson\u2019s disease","volume":"31","author":"Diederich","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120012_bb0670","doi-asserted-by":"crossref","first-page":"117039","DOI":"10.1016\/j.jns.2020.117039","article-title":"Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis","volume":"417","author":"Chipika","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jns.2021.120012_bb0675","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.120012_bb5000","doi-asserted-by":"crossref","first-page":"106835","DOI":"10.1016\/j.clineuro.2021.106835","article-title":"Rapidly progressive dementia and Parkinsonism as the first symptoms of dural arteriovenous fistula. The Sapienza University experience and comprehensive literature review concerning the clinical course of 102 patients","volume":"208","author":"Armocida","year":"2021","journal-title":"Clin Neurol Neurosurg."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:57:43Z","timestamp":1758383863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21027088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":136,"alternative-id":["S0022510X21027088"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The etiopathogenetic and pathophysiological spectrum of parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120012"}}